Insights Library

Review our latest comprehensive white papers, informative webinars, and illuminating case studies.

SR-Pharmacokinetics-Hero-1

White Papers

Learn more about our expertise

Efficient Drug Discovery Powered by High Accuracy A.I. Models

Download our white paper to discover how Southern Research accelerates drug discovery through innovative practices.

Ensuring the Safety of Novel Viral Vector Platforms

Download our white paper to learn how we assess neurovirulence and neurotoxicity for responsible development of viral-based medicines.

Mission Ready: Prepared to Respond to the Next Pandemic

Download our white paper to learn how Southern Research provides expertise in developing new treatments against seasonal influenza.

CASE STUDY: Southern Research Enables Fortune 500 Pharmaceutical Company to Rapidly File IND Application

A Fortune 500 pharmaceutical company approached SR about testing a prophylactic molecule in reducing or preventing influenza infection in a ferret model. Download the case study here to learn more.

CASE STUDY: Southern Research Successfully Tests BioNTech MPXV Vaccine in NHPs

German biotechnology company BioNTech SE approached Southern Research to test the efficacy of their prophylactic (mRNA vaccine) against highly pathogenic MPXV Zaire strain in non-human primates (NHPs). Download the case study here to learn more.

CASE STUDY: Southern Research Enables Accelerated Timeline for Pharmaceutical Company’s Therapeutics for Monkeypox Virus

A medium-sized pharmaceutical company approached Southern Research (SR) to test the efficacy of their therapeutic molecules against highly pathogenic MPXV, Zaire strain in non-human primates (NHPs). Download the case study here to learn more.

SR-Oncology-Webinar-Graphic-Image-1

Oncology Webinar

The tumor immune microenvironment (TIME) plays a major role in tumor progression, therapy response, and ultimate prognosis. Therefore, key cells, pathways, and proteins within the TIME are being evaluated as targets for new cancer drugs. Watch as Dr. Rebecca Boohaker, our Director of Oncology, highlights progress in three drug discovery initiatives that use this interdisciplinary approach to target immune suppression in the TIME.

Watch Now

Harry Ledebur, Ph.D.

Chief Operating Officer

Corinne E.
Augelli-Szafran, Ph.D.

Vice President of Research Fellows

Donghui Bao, Ph.D.

Scientist III

Jennifer Pickens, Ph.D.

Director of Infectious Disease Research

Joseph Randall, Ph.D.

Director of Toxicology

Rebecca Boohaker, Ph.D.

Director of Oncology

Paige N. Vinson, Ph.D.

Director, High-Throughput Screening

Sixue Zhang, Ph.D.

Head of A.I. Drug Discovery

Southern Research News

Southern Research leader Augelli-Szafran named 2024 National Academy of Inventors Fellow 

December 11, 2024

Southern Research leader Augelli-Szafran named 2024 National Academy of Inventors Fellow     BIRMINGHAM, AL. Dec...
Read More
Biotech incubator Station 41 fills up with plans to expand

Biotech incubator Station 41 fills up with plans to expand

November 21, 2024

Southern Research’s biotech incubator, Station 41 fills up with plans to expand. The pilot space for the Incubator was unveiled in January 2024 with twelve private leasable wet labs (325-625 square feet) and 13 private offices (125-200 sq. ...
Read More

MyOme and Broad Clinical Labs to support Southern Research program to bring genetics-driven health insights to Alabamians free of charge

October 14, 2024

MyOme, Inc., a leading clinical genetics innovation company, and Broad Clinical Labs (BCL), a world expert in whole genome sequencing (WGS) are announcing a collaboration to support the Southern Research (SR) program, Catalyst. SR is a leading nonprofit research organization committed to advan...
Read More